Cargando…

Correlation of blood bone turnover biomarkers and Wnt signaling antagonists with AS, DISH, OPLL, and OYL

BACKGROUND: Wnt signaling plays an important role in development and maintenance of many organs and tissues. The most-studied secreted Wnt inhibitors are sclerostin (SOST), Dickkopf-related protein 1 (DKK-1), and secreted frizzled related protein 1 (SFRP-1) which play important roles in bone turnove...

Descripción completa

Detalles Bibliográficos
Autores principales: Niu, Chi-Chien, Lin, Song-Shu, Yuan, Li-Jen, Chen, Lih-Huei, Yang, Chuen-Yung, Chung, An-Ni, Lu, Meng-Ling, Tsai, Tsung-Ting, Lai, Po-Liang, Chen, Wen-Jer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5290649/
https://www.ncbi.nlm.nih.gov/pubmed/28153008
http://dx.doi.org/10.1186/s12891-017-1425-4
_version_ 1782504675647422464
author Niu, Chi-Chien
Lin, Song-Shu
Yuan, Li-Jen
Chen, Lih-Huei
Yang, Chuen-Yung
Chung, An-Ni
Lu, Meng-Ling
Tsai, Tsung-Ting
Lai, Po-Liang
Chen, Wen-Jer
author_facet Niu, Chi-Chien
Lin, Song-Shu
Yuan, Li-Jen
Chen, Lih-Huei
Yang, Chuen-Yung
Chung, An-Ni
Lu, Meng-Ling
Tsai, Tsung-Ting
Lai, Po-Liang
Chen, Wen-Jer
author_sort Niu, Chi-Chien
collection PubMed
description BACKGROUND: Wnt signaling plays an important role in development and maintenance of many organs and tissues. The most-studied secreted Wnt inhibitors are sclerostin (SOST), Dickkopf-related protein 1 (DKK-1), and secreted frizzled related protein 1 (SFRP-1) which play important roles in bone turnover. The present study investigated the relationship between serum Wnt inhibitors and diseases with excessive ossification structures, such as ossification of posterior longitudinal ligament (OPLL), ankylosing spondylitis (AS), diffuse idiopathic skeletal hyperostosis (DISH), and ossification of yellow ligament (OYL). METHODS: Twenty-five patients with AS, DISH, OPLL, or OYL were recruited in this study. Fasting peripheral blood samples were collected from all patients and nine controls. Various biomarkers of bone turnover including osteocalcin (OSC), osteoprotegerin (OPG), SFRP-1, DKK-1, and SOST were investigated. RESULTS: Our data showed that serum levels of OSC were higher, but Dkk-1 levels were lower in AS, DISH, OPLL, and OYL patients than those in the controls. Serum levels of SFRP-1 were significantly higher in DISH patients than those in the controls. Serum levels of SOST were significantly higher in DISH and OPLL patients than both levels in the controls. Serum levels of OPG were lower in AS patients than those in the controls. Serum levels of OSC were higher in the OPLL patients than those in the AS patients. Serum levels of DKK-1, SFRP-1, SOST, and OPG were not significantly different between the different disease groups. CONCLUSIONS: In this exploratory study, both OSC and DKK-1 levels are correlated with the clinical conditions associated with excessive ossification, indicating that blood OSC and DKK-1 levels may serve as diagnostic biomarkers for AS, DISH, OPLL, and OYL. These findings may also help discover potential drug therapies for management of these diseases in the future.
format Online
Article
Text
id pubmed-5290649
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-52906492017-02-07 Correlation of blood bone turnover biomarkers and Wnt signaling antagonists with AS, DISH, OPLL, and OYL Niu, Chi-Chien Lin, Song-Shu Yuan, Li-Jen Chen, Lih-Huei Yang, Chuen-Yung Chung, An-Ni Lu, Meng-Ling Tsai, Tsung-Ting Lai, Po-Liang Chen, Wen-Jer BMC Musculoskelet Disord Research Article BACKGROUND: Wnt signaling plays an important role in development and maintenance of many organs and tissues. The most-studied secreted Wnt inhibitors are sclerostin (SOST), Dickkopf-related protein 1 (DKK-1), and secreted frizzled related protein 1 (SFRP-1) which play important roles in bone turnover. The present study investigated the relationship between serum Wnt inhibitors and diseases with excessive ossification structures, such as ossification of posterior longitudinal ligament (OPLL), ankylosing spondylitis (AS), diffuse idiopathic skeletal hyperostosis (DISH), and ossification of yellow ligament (OYL). METHODS: Twenty-five patients with AS, DISH, OPLL, or OYL were recruited in this study. Fasting peripheral blood samples were collected from all patients and nine controls. Various biomarkers of bone turnover including osteocalcin (OSC), osteoprotegerin (OPG), SFRP-1, DKK-1, and SOST were investigated. RESULTS: Our data showed that serum levels of OSC were higher, but Dkk-1 levels were lower in AS, DISH, OPLL, and OYL patients than those in the controls. Serum levels of SFRP-1 were significantly higher in DISH patients than those in the controls. Serum levels of SOST were significantly higher in DISH and OPLL patients than both levels in the controls. Serum levels of OPG were lower in AS patients than those in the controls. Serum levels of OSC were higher in the OPLL patients than those in the AS patients. Serum levels of DKK-1, SFRP-1, SOST, and OPG were not significantly different between the different disease groups. CONCLUSIONS: In this exploratory study, both OSC and DKK-1 levels are correlated with the clinical conditions associated with excessive ossification, indicating that blood OSC and DKK-1 levels may serve as diagnostic biomarkers for AS, DISH, OPLL, and OYL. These findings may also help discover potential drug therapies for management of these diseases in the future. BioMed Central 2017-02-02 /pmc/articles/PMC5290649/ /pubmed/28153008 http://dx.doi.org/10.1186/s12891-017-1425-4 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Niu, Chi-Chien
Lin, Song-Shu
Yuan, Li-Jen
Chen, Lih-Huei
Yang, Chuen-Yung
Chung, An-Ni
Lu, Meng-Ling
Tsai, Tsung-Ting
Lai, Po-Liang
Chen, Wen-Jer
Correlation of blood bone turnover biomarkers and Wnt signaling antagonists with AS, DISH, OPLL, and OYL
title Correlation of blood bone turnover biomarkers and Wnt signaling antagonists with AS, DISH, OPLL, and OYL
title_full Correlation of blood bone turnover biomarkers and Wnt signaling antagonists with AS, DISH, OPLL, and OYL
title_fullStr Correlation of blood bone turnover biomarkers and Wnt signaling antagonists with AS, DISH, OPLL, and OYL
title_full_unstemmed Correlation of blood bone turnover biomarkers and Wnt signaling antagonists with AS, DISH, OPLL, and OYL
title_short Correlation of blood bone turnover biomarkers and Wnt signaling antagonists with AS, DISH, OPLL, and OYL
title_sort correlation of blood bone turnover biomarkers and wnt signaling antagonists with as, dish, opll, and oyl
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5290649/
https://www.ncbi.nlm.nih.gov/pubmed/28153008
http://dx.doi.org/10.1186/s12891-017-1425-4
work_keys_str_mv AT niuchichien correlationofbloodboneturnoverbiomarkersandwntsignalingantagonistswithasdishopllandoyl
AT linsongshu correlationofbloodboneturnoverbiomarkersandwntsignalingantagonistswithasdishopllandoyl
AT yuanlijen correlationofbloodboneturnoverbiomarkersandwntsignalingantagonistswithasdishopllandoyl
AT chenlihhuei correlationofbloodboneturnoverbiomarkersandwntsignalingantagonistswithasdishopllandoyl
AT yangchuenyung correlationofbloodboneturnoverbiomarkersandwntsignalingantagonistswithasdishopllandoyl
AT chunganni correlationofbloodboneturnoverbiomarkersandwntsignalingantagonistswithasdishopllandoyl
AT lumengling correlationofbloodboneturnoverbiomarkersandwntsignalingantagonistswithasdishopllandoyl
AT tsaitsungting correlationofbloodboneturnoverbiomarkersandwntsignalingantagonistswithasdishopllandoyl
AT laipoliang correlationofbloodboneturnoverbiomarkersandwntsignalingantagonistswithasdishopllandoyl
AT chenwenjer correlationofbloodboneturnoverbiomarkersandwntsignalingantagonistswithasdishopllandoyl